Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (1)

Search Parameters:
Keywords = chiari type II

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
11 pages, 1777 KiB  
Article
Non-Targeted Metabolic Profiling of Cerebellum in Spina Bifida Fetal Rats
by Evan Thielen, Marc Oria, Miki Watanabe-Chailland, Kristin Lampe, Lindsey Romick-Rosendale and Jose L. Peiro
Metabolites 2023, 13(5), 670; https://doi.org/10.3390/metabo13050670 - 19 May 2023
Cited by 1 | Viewed by 2088
Abstract
Spina bifida, known more commonly as myelomeningocele, is a neural tube defect that results in herniation of the cerebellum through the foramen magnum into the central canal as part of the Chiari II malformation. Effects stemming from the herniated cerebellum and its metabolic [...] Read more.
Spina bifida, known more commonly as myelomeningocele, is a neural tube defect that results in herniation of the cerebellum through the foramen magnum into the central canal as part of the Chiari II malformation. Effects stemming from the herniated cerebellum and its metabolic profile have not been extensively studied. The objective of this study is to examine the metabolic effects of this disease on the cerebellum in utero through the utilization of a retinoid acid-induced Spina bifida rat model. Analysis of this model at mid-late (day 15) and term (day 20) of gestation in comparison to both non-exposed and retinoic acid-exposed non-myelomeningocele controls, the observed metabolic changes suggest that mechanisms of oxidative stress and energy depletion are at play in this neuro tissue. These notable mechanisms are likely to result in further damage to neural tissue as the fetus grows and the compressed cerebellum develops and herniates more due to myelomeningocele. Full article
(This article belongs to the Section Metabolomic Profiling Technology)
Show Figures

Figure 1

Back to TopTop